NCT01779609: ET-blockade and Exercise-induced Vascular Adaptations in T2DM |
|
|
| Completed | 4 | 19 | Europe | Bosentan, Tracleer, actelion pharmaceuticals, Placebo, Exercise, Supervised Exercise Training Program | Radboud University Medical Center, Actelion | Type 2 Diabetes Mellitus | 12/13 | 12/13 | | |
NCT01779596: ET-blockade and Exercise Induced Blood Flow in T2DM |
|
|
| Completed | 4 | 22 | Europe | Bosentan, Tracleer, actelion pharmaceuticals, 125 mg oral dose, Placebo | Radboud University Medical Center | Type 2 Diabetes Mellitus | 12/13 | 12/13 | | |
